Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT for Primary Sclerosing Cholangitis
NCT02424175Phase 2Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- Feb 2016
- Primary completion
- Aug 2017
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of allogeneic fecal microbiota in Primary Sclerosing Cholangitis (PSC), sponsored by Brigham and Women's Hospital. Started Feb 2016; status: completed.
02
Drugs
allogeneic fecal microbiota
03
Conditions
Primary Sclerosing Cholangitis (PSC)
Beyond the preview
Go deeper on NCT02424175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02424175.